Equities

Feedback PLC

FDBK:LSE

Feedback PLC

Health CareMedical Equipment and Services
  • Price (GBX)73.50
  • Today's Change-1.50 / -2.00%
  • Shares traded4.71k
  • 1 Year change-31.63%
  • Beta1.7490
Data delayed at least 20 minutes, as of Jun 28 2024 16:15 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Feedback PLC had net income fall 37.74% from a loss of 2.12m to a larger loss of 2.92m despite a 74.15% increase in revenues from 588.58k to 1.03m.
Gross margin90.60%
Net profit margin-393.47%
Operating margin-444.13%
Return on assets-30.44%
Return on equity-32.67%
Return on investment-32.67%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Feedback PLC fell by 2.99m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 1.79m for operations while cash used for investing totalled 1.20m.
Cash flow per share-0.1959
Price/Cash flow per share--
Book value per share0.6726
Tangible book value per share0.3793
More ▼

Balance sheet in GBPView more

Feedback PLC appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio6.52
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.